Experts are closely watching the drug , a experimental therapeutic targeting tau tangles , a significant hallmark of the debilitating disease . Distinct from many prior attempts focused on amyloid https://semorinemab-in-stock-rea159913.aboutyoublog.com/54327688/semorinemab-a-emerging-hope-for-the-condition